Stay updated with breaking news from Schott pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gerresheimer CEO Dietmar Siemssen said he expects about 4% of the company s revenue growth per year from deals to supply makers of drugs for weight loss and diabetes with vials, cartridges, syringes. ....
Weight-Loss Drug Deals to Drive Around 4% of Gerresheimer Yearly Growth, CEO Says usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
Weight-loss drug deals to drive around 4 percent of Gerresheimer yearly growth, reveals CEO financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Stevanato: Destocking And Valuation Risk (NYSE:STVN) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.